Cherry Creek Investment Advisors Inc. Purchases Shares of 2,713 Addus HomeCare Co. (NASDAQ:ADUS)

Cherry Creek Investment Advisors Inc. bought a new position in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 2,713 shares of the company's stock, valued at approximately $340,000.

A number of other institutional investors have also recently bought and sold shares of the stock. Janney Montgomery Scott LLC lifted its stake in shares of Addus HomeCare by 0.9% in the 4th quarter. Janney Montgomery Scott LLC now owns 10,691 shares of the company's stock valued at $1,340,000 after purchasing an additional 91 shares in the last quarter. Inspire Investing LLC raised its holdings in Addus HomeCare by 3.3% in the third quarter. Inspire Investing LLC now owns 3,111 shares of the company's stock valued at $414,000 after buying an additional 100 shares during the period. New York State Teachers Retirement System lifted its position in Addus HomeCare by 1.2% during the third quarter. New York State Teachers Retirement System now owns 8,510 shares of the company's stock valued at $1,132,000 after buying an additional 100 shares in the last quarter. Equitable Trust Co. grew its stake in Addus HomeCare by 2.2% during the third quarter. Equitable Trust Co. now owns 4,825 shares of the company's stock worth $642,000 after buying an additional 106 shares during the period. Finally, Royce & Associates LP lifted its holdings in shares of Addus HomeCare by 1.2% during the 3rd quarter. Royce & Associates LP now owns 8,924 shares of the company's stock valued at $1,187,000 after acquiring an additional 109 shares in the last quarter. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Addus HomeCare

In other news, CEO R Dirk Allison sold 25,000 shares of the company's stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the completion of the transaction, the chief executive officer now directly owns 79,397 shares of the company's stock, valued at approximately $9,905,569.72. This represents a 23.95 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Roberton James Stevenson sold 2,250 shares of the firm's stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the sale, the executive vice president now directly owns 10,217 shares in the company, valued at approximately $1,236,257. This trade represents a 18.05 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 39,750 shares of company stock valued at $4,930,750. Corporate insiders own 4.60% of the company's stock.

Addus HomeCare Stock Performance

Shares of Addus HomeCare stock traded down $1.17 during trading on Friday, reaching $125.16. The company had a trading volume of 157,608 shares, compared to its average volume of 143,904. Addus HomeCare Co. has a fifty-two week low of $85.94 and a fifty-two week high of $136.72. The firm's fifty day moving average is $126.84 and its 200-day moving average is $127.25. The company has a market cap of $2.27 billion, a price-to-earnings ratio of 28.64, a price-to-earnings-growth ratio of 1.63 and a beta of 1.00.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.02. The firm had revenue of $289.80 million for the quarter, compared to analysts' expectations of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Addus HomeCare's revenue for the quarter was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.03 earnings per share. On average, research analysts anticipate that Addus HomeCare Co. will post 4.58 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

ADUS has been the topic of several analyst reports. KeyCorp started coverage on Addus HomeCare in a report on Friday, October 11th. They set an "overweight" rating and a $150.00 target price on the stock. StockNews.com raised shares of Addus HomeCare from a "hold" rating to a "buy" rating in a research report on Friday, January 24th. Oppenheimer raised their price target on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a report on Friday, January 24th. JMP Securities started coverage on shares of Addus HomeCare in a report on Monday, December 16th. They issued an "outperform" rating and a $150.00 price objective on the stock. Finally, Macquarie reissued an "outperform" rating and issued a $139.00 price objective on shares of Addus HomeCare in a research report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, nine have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, Addus HomeCare currently has an average rating of "Buy" and an average price target of $134.22.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.